Iloprost, a prostacyclin (PGI2) analogue, reduces liver injury in hepatic ischemia-reperfusion in rats

Acta Cirurgica Brasileira

Volumn 24, Issue 3, 2009, Pages 226-232

  Gediki, Ercan ^a   Girgin, Sadullah ^a   Obay, Basra Deniz ^a   Ozturk, Hayrettin ^b   Ozturk, Hulya ^c   Buyukbayram, Huseyin ^a  

^a DICLE UNIVERSITY   (Turkey)

^b ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^c DUZCE UNIVERSITY   (Turkey)

Author keywords

Iloprost; Ischemia; Liver; Rats; Reperfusion

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CATALASE; GLUTATHIONE; ILOPROST; MALONALDEHYDE; SUPEROXIDE DISMUTASE; ANTITHROMBOCYTIC AGENT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL STRUCTURE; CELL VACUOLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; EVALUATION; HISTOPATHOLOGY; LIVER CELL; LIVER INJURY; LIVER ISCHEMIA; LIVER PROTECTION; MALE; NONHUMAN; RAT; REPERFUSION INJURY; SHAM PROCEDURE; SPRAGUE DAWLEY RAT; ANALYSIS OF VARIANCE; ANIMAL; DISEASE MODEL; DRUG SCREENING; LIVER; OXIDATIVE STRESS; RANDOMIZATION; VASCULARIZATION;

ANALYSIS OF VARIANCE; ANIMALS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; ILOPROST; LIVER; MALE; OXIDATIVE STRESS; PLATELET AGGREGATION INHIBITORS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 67649760245     PISSN: 01028650     EISSN: 16782674     Source Type: Journal    
DOI: 10.1590/S0102-86502009000300012     Document Type: Article

References (34)

1. Serracino-Inglott F, Habib NA, Mathie RT. Hepatic ischemia-reperfusion injury. Am J Surg. 2001;181:160-166 (Pubitemid 32406311)
2. Giakoustidis D, Papageorgiou G, Iliadis S, Kontos N, Kostopoulou E, Papachrestou A, Tsantilas D, Spyridis C, Takoudas D, Botsoglou N, Dimitriadou A, Giakoustidis E.Intramuscular administration of very high dose of alpha-tocopherol protects liver from severe ischemia/reperfusion injury. World J Surg. 2002;26:872-877 (Pubitemid 36920332)
3. Suzuki S, Toledo-Pereyra LH. Interleukin 1 and tumor necrosis factor production as the initial stimulants of liver ischemia and reperfusion injury. J Surg Res. 1994;57:253-258 (Pubitemid 24262396)
4. Shibuya H, Ohkohchi N, Tsukamoto S, Satomi S. Tumor necrosis factor-induced, superoxide-mediated neutrophil accumulation in cold ischemic/reperfused rat liver. Hepatology. 1997;26:113-120 (Pubitemid 27280314)
5. Palma-Vargas JM, Toledo-Pereyra L, Dean RE, Harkema JM, Dixon RA, Kogan TP. Small-molecule selectin inhibitor protects against liver inflammatory response after ischemia and reperfusion. J Am Coll Surg. 1997;185:365-372 (Pubitemid 27419194)
6. Adkison D, Höllwarth ME, Benoit JN, Parks DA, McCord JM, Granger DN. Role of free radicals in ischemia-reperfusion injury to the liver. Acta Physiol Scand Suppl. 1986;548:101-107 (Pubitemid 16090302)
7. Gonzalez-Flecha B, Cutrin JC, Boveris A. Time course and mechanism of oxidative stress and tissue damage in rat liver subjected to in vivo ischemia-reperfusion. J Clin Invest. 1993;91.456-64
8. Jaescke H. Mechanism of reperfusion injury after warm ischemia of the liver. J. Hepatobil Pancreat Surg. 1998;5:402-408 (Pubitemid 128662611)
9. Koksel O, Ozdulger A, Aytacoglu B, Tamer L, Polat A, Sucu N, Yildirim C, Degirmenci U, Kanik A. The influence of iloprost on acute lung injury induced by hind limb ischemia-reperfusion in rats. Pulm Pharmacol Ther. 2005;18:235-241 (Pubitemid 40385063)
10. Mazzone A, Mazzucchelli I, Fossati G, Gritti D, Girola S, Canale C, Cusa C, Ricevuti G. Iloprost effects on phagocytes in patients suffering from ischaemic diseases: in vivo evidence for down-regulation of aMb2 integrin. Eur J Clin Invest. 1996;26:860-866 (Pubitemid 26343775)
11. Thomson IA, Egginton S, Slimms MH, Hudlicka O. Effect of muscle ischemia and iloprost during femorodistal reconstruction on capillary endothelial swelling. Int J Microcirc Clin Exp. 1996;16:284-290
12. McNamara DB, Champion HC, Kadowitz PJ. Nonoperative management of lower extremity arterial disease. Part I. Pharmocologic management of peripheral vascular disease. Surg Clin North Am. 1998;78:447-456
13. Blebea J, Cambria RA, DeFouw D, Feinberg RN, Hobson RW, Duran WN. Iloprost attenuates the increased permeability in skeletal muscle after ischemia and reperfusion. J Vasc Surg. 1990;12:657-665
14. Sepodes B, Maio R, Pinto R, Marques C, Mendes-do-Vale J, McDonald MC, Thiemermann C, Mota-Filipe H. Tempol, an intracelullar free radical scavenger, reduces liver injury in hepatic ischemia-reperfusion in the rat. Transplant Proc. 2004;36:849-853 (Pubitemid 38766197)
15. Ozturk H, Gezici A, Ozturk H. The effect of celecoxib, a selective COX-2 inhibitor, on liver ischemia/reperfusion-induced oxidative stress in rats. Hepatol Res. 2006;34:76-83. (Pubitemid 43137555)
16. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254
17. Wasowicz W, Neve J, Peretz A. Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin Chem. 1993;39:2522-2526 (Pubitemid 24008241)
18. McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem. 1969;244:6049-6055
19. Beers RF Jr, Sizer IW. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem. 1952;195:133-140
20. Lawrence A, Burk RF. Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun. 1976;71:952-958
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:265-275
22. Ishizaki N, Zhu Y, Zhang S, Nemoto A, Kobayashi Y, Subbotin V, Starzl TE, Todo S. Comparison of various lazaroid compounds for protection against ischemic liver injury. Transplantation. 1997;63:202-208 (Pubitemid 27121199)
23. Yokota R, Fukai M, Shimamura T, Suzuki T, Watanabe Y, Nagashima K, Kishida A, Furukawa H, Hayashi T, Todo S. A novel hydroxyl radical scavenger, nicaraven, protects the liver from warm ischemia and reperfusion injury. Surgery. 2000;127:661-669 (Pubitemid 30399058)
24. Zar HA, Tanigawa K, Kim YM, Lancaster JR Jr. Rat liver postischemic lipid peroxidation and vasoconstriction depend on ischemia time. Free Radic Biol Med. 1998;25:255-264 (Pubitemid 28326199)
25. Akar H, Saraç Konuralp C, Yildiz L, Kolbakir F. Comparison of histopathologic effects of carnitine and ascorbic acid on reperfusion injury. Eur J Cardiothorac Surg. 2001;19:500-506 (Pubitemid 32297782)
26. Baltalarli A, Ozcan V, Bir F, Aybek H, Sacar M, Onem G, Goksin I, Demir S, Teke Z. Ascorbic acid (vitamin C) and iloprost attenuate the lung injury caused by ischemia/reperfusion of the lower extremities of rats. Ann Vasc Surg. 2006;20:49-55. (Pubitemid 43029858)
27. Carden DL, Granger DN. Pathophysiology of ischemia-reperfusion injury. J Pathol. 2000;190:255-266
28. Rowlands TE, Gough MJ, Homer-Vanniasinkam S. Do prostaglandins have a salutary role in skeletal muscle ischaemia-reperfusion injury? Eur J Vasc Endovasc Surg. 1999;18:439-444
29. Vane J, Corin RE. Prostacyclin a vascular mediator. Eur J Vasc Endovasc Surg. 2003;26:571-578 (Pubitemid 37461770)
30. Grant SM, Goa KL. Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischemia and extracorporeal circulation procedures. Drugs. 1992;43:889-924.
31. Kawashima M, Nakamura T, Schneider S, Vollmar B, Lausberg HF, Bauer M, Menger MD, Schäfers HJ. Iloprost ameliorates post-ischemic lung reperfusion injury and maintains an appropriate pulmonary ET-1 balance. J Heart Lung Transplant. 2003;22:794-801. (Pubitemid 36842932)
32. Chang EJ, Lee SH, Mun KC, Suh SI, Bae JH, Kim SP, Choi HJ, Cho KB, Hwang JS. Effect of artificial cells on hepatic function after ischemia-reperfusion injury in liver. Transplant Proc. 2004;36:1959-1961 (Pubitemid 39424291)
33. Zimmerman BJ, Granger DN. Reperfusion injury. Surg Clin North Am. 1992;72:65-83.
34. Reilly PM, Schiller HJ, Bulkley GB. Pharmacologic approach to tissue injury mediated by free radicals and other reactive oxygen metabolites. Am J Surg. 1991;161:488-503.